Search Videos and More
GENITOURINARY CANCER PROGRAM
Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship ServicesThe Multidisciplinary Approach at Fox Chase Cancer Center
Where your patient starts their cancer journey matters. Behind every patient at Fox Chase Cancer Center is a multidisciplinary team of highly experienced and trained specialists who provide compassionate care and ensure the best possible outcomes with theFEMALE PELVIC MEDICINE & RECONSTRUCTIVE SURGERY
Fox Chase – Temple Urologic Institute’s program is a comprehensive center serving women with pelvic floor disorders such as incontinence and pelvic order prolapse. Our team has extensive training and experience in the diagnosis and treatment of conditions that affect the pelvic organs. We partner closely with you and your primary care physician, OB/GYN, and urologistto ensure you have the highest level of pelvic care.BENIGN PROSTATE HYPERPLASIA
With one of the largest and most experienced urology teams in the region and the latest treatment capabilities, the Fox Chase-Temple Urologic Institute is a trusted regional leader in treating all types of urologic conditions. Our physicians are available to assist with diagnosing and treating benign prostate hyperplasia, including seeing patients for whom other medical treatments have failed.Like Mother, Like Son
A mother and son’s talents and a duo of DAISY awards.23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations of the 2024 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available. This CME program is designed to address the challenges physicians face in treating these complex cases. Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.Fox Chase Cancer Center and Lewis Katz School of Medicine Researchers Identify Where to Target Interventions to Reduce Disparities in Aggressive Prostate Cancer
Researchers at Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University have identified factors that, if addressed, could decrease incidence of aggressive prostate cancer in areas where rates are highest — often Black communities with high rates of poverty.Tackling Anything Patients Need Before, During, and After Urologic Surgery
Growing up, Mary Ellen Day was athletic and focused—dreaming that one day, she would become a ‘real’ cheerleader.Fox Chase Cancer Center Welcomes Dr. J. Ryan Mark
Fox Chase Cancer Center is pleased to announce the hiring of J. Ryan Mark, MD, FACS, as an Associate Professor in the Department of Urology at Fox Chase Cancer Center and a Fox Chase – Temple Urologic Institute provider.ENDING THE RELIANCE ON BCG
A Phase III clinical trial for bladder cancer
DEPARTMENT OF HEMATOLOGY/ONCOLOGY THORACIC CANCERS CLINICAL TRIALS
For general questions about clinical trials, call 215-214-1515 or visit FoxChase.org/ClinicalTrials.